Equities
Health CareMedical Equipment and Services
  • Price (JPY)1,280.00
  • Today's Change-45.00 / -3.40%
  • Shares traded5.98m
  • 1 Year change-53.65%
  • Beta0.6960
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.

  • Revenue in JPY (TTM)502.95bn
  • Net income in JPY44.75bn
  • Incorporated1968
  • Employees10.53k
  • Location
    Sysmex Corp1-5-1, Wakinohama Kaigandori, Chuo-kuKOBE-SHI 651-0073JapanJPN
  • Phone+81 782650500
  • Fax+81 782650524
  • Websitehttps://www.sysmex.co.jp
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
6869:TYO since
announced
Transaction
value
JEOL Ltd-Medical Equipment BusinessAnnounced02 Sep 202502 Sep 2025Announced-32.06%--
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
As One Corp107.58bn8.97bn168.04bn731.0017.822.3215.571.56125.12125.121,500.44959.871.126.053.11147,174,000.009.387.8112.6210.7230.4230.598.348.062.24--0.072751.928.608.079.726.64-16.129.16
Mani Inc30.14bn4.94bn170.88bn4.14k31.842.8822.935.6750.1650.16305.99555.200.51561.6110.587,280,435.008.4510.449.0711.1964.6163.2116.4021.956.27--0.001261.755.1014.54-26.146.8831.5612.13
Nakanishi Inc81.18bn-2.40bn234.70bn2.18k--1.8568.792.89-29.41-29.41969.191,373.650.50981.398.47---1.518.35-1.849.7356.7459.43-2.9516.562.57--0.190138.605.3719.69-127.96--34.8412.47
Ship Healthcare Holdings Inc708.37bn13.99bn257.01bn7.81k18.181.6912.250.3628149.82149.827,579.631,609.071.8518.395.1990,758,740.003.573.657.207.009.4110.411.932.251.16--0.15633.317.496.969.715.091.879.11
Nipro Corp652.61bn15.20bn258.65bn39.17k18.500.96443.160.396381.5681.563,649.421,564.270.55641.793.9316,661,790.001.451.112.371.7130.1029.842.612.010.7634.880.675242.899.857.81-53.97--5.7413.12
Nihon Kohden Corp230.96bn12.37bn290.55bn6.11k22.451.6016.291.2675.6975.691,415.011,062.470.93691.813.8837,775,760.005.048.436.5411.0851.8851.545.388.492.31--0.12928.591.554.03-17.207.4319.3912.12
Fukuda Denshi Co Ltd138.47bn17.96bn342.37bn3.47k14.121.3611.642.47642.29642.294,964.156,648.580.6513.954.0939,962,190.008.448.579.8010.6354.0050.2812.9712.343.32--0.009829.45-0.93780.8279-0.470814.13-0.247916.80
Alfresa Holdings Corporation3.06tn33.64bn478.92bn12.45k13.530.91629.820.1564185.04185.0416,819.642,732.391.9014.394.14245,889,200.002.112.056.105.337.077.171.111.021.02--0.056942.103.591.87-7.34-7.42-0.43934.73
ASAHI INTECC CO., LTD.129.80bn17.69bn766.81bn9.47k43.584.8628.305.9166.3266.32482.54594.650.67251.497.1013,702,100.009.208.0910.389.5169.3466.0213.6813.783.49171.560.04735.6011.6016.24-19.436.77-2.4722.43
Sysmex Corp502.95bn44.75bn834.06bn10.53k18.461.659.291.6671.7871.78806.72803.690.74482.543.2147,749,460.006.608.707.9510.9451.8552.478.8710.982.4418.050.124138.1110.2110.998.129.0013.545.92
Olympus Corp987.51bn84.80bn1.80tn29.30k21.352.3011.781.8275.6175.63882.16702.360.68941.625.1233,706,730.005.926.748.279.5166.2466.858.5910.691.0923.110.235221.136.535.72342.6914.22-0.219414.87
Terumo Corp1.10tn127.90bn2.83tn30.69k22.021.8512.952.5886.7186.71742.711,032.040.52991.585.4835,696,600.006.196.147.687.2753.3352.5811.6811.690.8858--0.20831.0712.4010.509.976.54-0.269513.18
Data as of Feb 17 2026. Currency figures normalised to Sysmex Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

16.56%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 05 Feb 202618.47m2.93%
The Vanguard Group, Inc.as of 04 Feb 202616.44m2.61%
BlackRock Financial Management, Inc.as of 28 Nov 202511.28m1.79%
BlackRock Fund Advisorsas of 28 Nov 202510.29m1.63%
Harding Loevner LPas of 31 Dec 202510.00m1.59%
BlackRock Japan Co. Ltd.as of 28 Nov 20259.44m1.50%
Daiwa Asset Management Co. Ltd.as of 30 Jan 20267.96m1.26%
Amova Asset Management Co., Ltd.as of 06 Feb 20267.91m1.26%
Norges Bank Investment Managementas of 30 Jun 20256.32m1.00%
Geode Capital Management LLCas of 12 Feb 20266.11m0.97%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.